WINSON COMPETITIVE GUIDE
The National Aeronautics and Space Administration (NASA) for
the first time has successfully sequenced DNA in space aboard the
International Space Station (ISS). The genome sequencing was
undertaken for the first time in microgravity as part of the
Biomolecule Sequencer experiment performed by NASA astronaut
Kate Rubins.
Key Facts:
The experiments were undertaken by using commercially
available DNA sequencing device called MinION on samples of
mouse, virus and bacteria DNA.
The tests were set up for selected organisms whose DNA has
already been completely sequenced in an attempt to make
spaceflight conditions, primarily microgravity, the only variables
that could account for differences in results.
The technology demonstration experiments validated that the
device is durable enough to withstand vibration during launch and
can operate reliably in a microgravity environment.
AWARDS AND HONOURS:
21